"Pityriasis Rosea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.
| Descriptor ID |
D017515
|
| MeSH Number(s) |
C17.800.859.600.675
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pityriasis Rosea".
Below are MeSH descriptors whose meaning is more specific than "Pityriasis Rosea".
This graph shows the total number of publications written about "Pityriasis Rosea" by people in this website by year, and whether "Pityriasis Rosea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 1 | 4 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pityriasis Rosea" by people in Profiles.
-
Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine. Hum Vaccin Immunother. 2021 Nov 02; 17(11):4097-4098.
-
Pityriasis rosea following SARS-CoV-2 vaccination: A case series. J Cosmet Dermatol. 2021 Oct; 20(10):3080-3084.
-
Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e721-e722.
-
Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. Dermatol Ther. 2021 09; 34(5):e15040.
-
Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19. Dtsch Arztebl Int. 2021 06 25; 118(25):431.
-
Pityriasis rosea after mRNA COVID-19 vaccination. Int J Dermatol. 2021 Sep; 60(9):1150-1151.
-
Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e619-e620.
-
Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine. J Eur Acad Dermatol Venereol. 2021 09; 35(9):e546-e548.
-
Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection. Dermatol Ther. 2021 07; 34(4):e14972.
-
Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance. J Eur Acad Dermatol Venereol. 2021 Aug; 35(8):e489-e491.